07:00 , Jul 25, 2011 |  BC Week In Review  |  Company News

BioMimetix, Duke University deal

The university granted newco BioMimetix an exclusive license to develop a class of patented compounds to treat radiation toxicity incurred during the treatment of cancer. Terms were not disclosed. BioMimetix Pharmaceutical Inc. , Location not...